---
title: "Charles River Laboratories International Inc. Stock Outperforms Competitors Despite Losses On The Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292818324.md"
description: "Charles River Laboratories (CRL) shares fell 1.29% to $228.22, underperforming the broader market as the S&P 500 and Dow Jones rose. CRL closed 4.05% below its 52-week high. While competitors Labcorp and Alnylam also declined, Bio-Techne rose. Trading volume was below the 50-day average."
datetime: "2026-07-15T21:15:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292818324.md)
  - [en](https://longbridge.com/en/news/292818324.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292818324.md)
generator: "portal-rs"
---

# Charles River Laboratories International Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Charles River Laboratories International Inc. (CRL) slid 1.29% to $228.22 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.38% to 7,572.40 and the Dow Jones Industrial Average rising 0.29% to 52,658.64.

Charles River Laboratories International Inc. closed 4.05% below its 52-week high of $237.86, which the company achieved on July 10th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Labcorp Holdings Inc. (LH) fell 1.34% to $271.99, Alnylam Pharmaceuticals Inc. (ALNY) fell 0.75% to $279.14, and Bio-Techne Corp. (TECH) rose 0.35% to $71.48.

Trading volume (860,585) remained 48,811 below its 50-day average volume of 909,396.

Data source: Dow Jones Market Data, FactSet. Data compiled July 15, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-15-26 1715ET

### Related Stocks

- [CRL.US](https://longbridge.com/en/quote/CRL.US.md)

## Related News & Research

- [Charles River Laboratories to Present at Morgan Stanley and Baird Conferences | CRL Stock News](https://longbridge.com/en/news/298729646.md)
- [Should Automated Test Cartridge Expansion Require Action From Charles River Shares Investors?](https://longbridge.com/en/news/298786446.md)
- [Charles River expands Endosafe cartridge output with automated manufacturing suite](https://longbridge.com/en/news/298315263.md)
- [Charles River Laboratories Earnings Preview: What to Expect](https://longbridge.com/en/news/293235736.md)
- [Charles River Laboratories International Inc. Stock Underperforms Monday When Compared To Competitors](https://longbridge.com/en/news/297563074.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**